Live from the NIH registry
Studies recruiting near San Antonio right now
Top 25 of 1,026 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Consultants of Texas — Schertz, Texas (16.5 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - South San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: R1 Therapeutics
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Narcolepsy Type 1
Phase 3
Interventional 150 participants sought
Alkermes Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Alkermes, Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: SWOG Cancer Research Network
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Pasithea Therapeutics Corp.
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The University of Texas Health Science Center San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Element Research Group — San Antonio, Texas (3.3 mi)
· Sponsor: Philip Morris Products S.A.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — San Antonio, Texas (3.3 mi)
· Sponsor: AstraZeneca
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — San Antonio, Texas (3.3 mi)
· Sponsor: AstraZeneca
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Texas Oncology San Antonio Medical Center — San Antonio, Texas (3.3 mi)
· Sponsor: Daiichi Sankyo
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — San Antonio, Texas (3.3 mi)
· Sponsor: Avenzo Therapeutics, Inc.
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Sun Research Institute — San Antonio, Texas (3.3 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm
Phase 3
Interventional 70 participants sought
Vanda Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Vanda Pharmaceuticals
Evaluating Treatments for Suicidal Veterans With PTSD
Self-directed Violence, Post-traumatic Stress Disorder (PTSD)
N/A
Interventional 125 participants sought
South Texas Health Care System, San Antonio, TX — San Antonio, Texas (3.3 mi)
· Sponsor: VA Office of Research and Development
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Jaeb Center for Health Research
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
UT Health Sciences Center — San Antonio, Texas (3.3 mi)
· Sponsor: Baylor Research Institute
Comparing Antipsychotic Medications in LBD Over Time
Parkinson's Disease Psychosis, Dementia With Lewy Bodies
Phase 4
Interventional 94 participants sought
University Health System — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Rotator Cuff Repairs With or Without BioEnthesis™ Augmentation
Rotator Cuff Tears, Rotator Cuff Injuries
Phase 4
Interventional 100 participants sought
Brooke Army Medical Center — San Antonio, Texas (3.3 mi)
· Sponsor: Brooke Army Medical Center
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
MTAP-deleted Solid Tumors
Phase 1, Phase 2
Interventional 450 participants sought
START | San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Bayer
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,020 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Guardant Health, Inc.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Texas Oncology - San Antonio ( Site 8006) — San Antonio, Texas (3.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Discovery Clinical Trials — San Antonio, Texas (3.3 mi)
· Sponsor: Crystalys Therapeutics
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Cancer, Tumor, Solid
Phase 1, Phase 2
Interventional 168 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: OncoResponse, Inc.
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Parenteral Nutrition Associated Liver Disease (PNALD), Essential Fatty Acid Deficiency
N/A
Observational 40 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Fresenius Kabi